Delay in seeking treatment is still the main barrier in receiving acute stroke therapy

Stroke

Volumn 41, Issue 8, 2010, Pages

  Chan, Lung ^a  

^a Division of Neurology   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ACUTE ISCHEMIC STROKE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; HUMAN; LETTER; PRIORITY JOURNAL; TAIWAN;

FIBRINOLYTIC AGENTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; STROKE; TAIWAN; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 77955175150     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.586925     Document Type: Letter

References (8)

1. Department of Health, Executive Yuan, ROC, Taiwan. Statistics of causes of death 2008. Available at: http://www.doh.gov.tw/EN2006/DM/DM2.aspx? now-fod-list-no = 10864&class-no=390&level-no=2. Accessed April 8, 2010.
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
3. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewan-dowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S, ATLANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768-774.
4. Chang YJ, Ryu SJ, Chen JR, Hu HH, Yip PK, Chiu TF, Consensus Group of Taiwan Stroke Society. Guidelines for the general management of patients with acute ischemic stroke. Acta Neurol Taiwan. 2008;17:275-295.
5. Chao AC, Hsu HY, Chung CP, Liu CH, Chen CH, Teng MH, Peng GS, Sheng WY, Hu HH, the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Group. Outcomes of thrombolytic therapy for acute ischemic stroke in Chinese patients. The Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study. Stroke. 2010;41:885-890.
6. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G, for the SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282.
7. Jeng JS, Yip PK. Stroke center criteria highly influencing thrombolytic therapy administration for acute ischemic stroke: national survey of stroke center in Taiwan. J Stroke Cerebrovasc Dis. 2008;17(Suppl 1):S38.
8. Moser DK, Kimble LP, Alberts MJ, Croft JB, Dracup K, Evenson KR, Go AS, Hand MM, Kothari RU, Mensah GA, Morris DL, Pancioli AM, Riegel B, Zerwic JJ. Reducing delay in seeking treatment by patients with acute cronary syndrome and stroke: a scientific statement from the American Heart Association Council on Cardiovascular Nursing and Stroke Council. Circulation. 2006;114:168-182.